Page 246 - EJMO-9-3

Eurasian Journal of
Medicine and Oncology ICU pharmacists and clinical outcomes

expanded use of clinical pharmacist practitioners in addition unit mortality. Arch Intern Med. 2010;170(4):369-376.
to team-based care in a community health system intensive doi: 10.1001/archinternmed.2009.521
care unit. Am J Health Syst Pharm. 2015;72(1):47-53.
48. Baudouin A, Herledan C, Poletto N, et al. Economic impact of
doi: 10.2146/ajhp140105 clinical pharmaceutical activities in hospital wards: A systematic
46. Kopp BJ, Erstad BL, Allen ME, Theodorou AA, Priestley G. review. Res Social Adm Pharm. 2021;17(3):497-505.
Medication errors and adverse drug events in an intensive doi: 10.1016/j.sapharm.2020.07.016
care unit: Direct observation approach for detection. Crit
Care Med. 2006;34(2):415-425. 49. Dawoud DM, Smyth M, Ashe J, et al. Effectiveness and
cost effectiveness of pharmacist input at the ward level:
doi: 10.1097/01.CCM.0000198106.54306.D7 A systematic review and meta-analysis. Res Soc Adm Pharm.
2019;15(10):1212-1222.
47. Kim MM, Barnato AE, Angus DC, Fleisher LA, Kahn JM.
The effect of multidisciplinary care teams on intensive care doi: 10.1016/j.sapharm.2018.10.006

Volume 9 Issue 3 (2025) 238 doi: 10.36922/EJMO025150116